118-42-3

Hydroxychloroquine (2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol) (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9. It is a medication used to prevent and treat malaria, and it's also being studied as an experimental treatment for COVID-19.

(S)-Hydroxychloroquine is the enantiomer of Hydroxychloroquine. Hydroxychloroquine shows efficiently inhibits SARS-CoV-2 infection in vitro.

Hydroxychloroquine-D5 is a deuterated compound of Hydroxychloroquine. Hydroxychloroquine (T9287) has a CAS number of 118-42-3. Hydroxychloroquine (T9287) (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9. It is a medication used to prevent and treat malaria, and it's also being studied as an experimental treatment for COVID-19.

Hydroxychloroquine sulfate (Standard) is a reference standard for research and analysis in studies involving Hydroxychloroquine sulfate. Hydroxychloroquine sulfate (Acidum iopanoicum) inhibits plasmodial heme polymerase. It is a chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa.

Hydroxychloroquine sulfate (Acidum iopanoicum) inhibits plasmodial heme polymerase. It is a chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa.

Hydroxychloroquine-D5 (Standard) is a reference standard of Hydroxychloroquine-D5 intended for quantitative analysis, quality control, and related biochemical research applications. Hydroxychloroquine-d5 is a deuterated compound of Hydroxychloroquine. Hydroxychloroquine has a CAS number of 118-42-3. Hydroxychloroquine (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9. It is a medication used to prevent and treat malaria, and it's also being studied as an experimental treatment for COVID-19.

(R)-Hydroxychloroquine, the enantiomer of Hydroxychloroquine, is a synthetic antimalarial agent.

(R)-Hydroxychloroquine ((R)-HCQ) phosphate is an isomer of Hydroxychloroquine. It inhibits insulin-metabolizing enzymes in the cytosolic fraction of liver homogenates in both healthy and diabetic rats.

(S)-Hydroxychloroquine ((S)-HCQ) sulfate is an isomer of Hydroxychloroquine. At concentrations of 2.5-20 mg/mL, (S)-Hydroxychloroquine sulfate can reduce the rate of insulin degradation in liver homogenates isolated from both non-diabetic and diabetic rats. Preparations containing Hydroxychloroquine have been used in studies of malaria, rheumatoid arthritis, and systemic lupus erythematosus.